Which blood tests should be obtained for children with avoidant/restrictive food intake disorder (ARFID) to screen for anemia, nutrient deficiencies, electrolyte disturbances, and organ dysfunction, and why?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Work for Children with ARFID

Children with ARFID require screening for anemia (CBC with indices), iron deficiency (ferritin, transferrin saturation), and key micronutrient deficiencies (vitamins B1, B2, B12, C, K, zinc, potassium) because their restricted dietary patterns create high risk for multiple nutritional deficiencies that can impair growth and neurodevelopment.

Core Laboratory Panel

Complete Blood Count with Indices

  • Obtain CBC with MCV, RDW, and reticulocyte count as the foundation of your workup 1
  • MCV classifies anemia as microcytic, normocytic, or macrocytic and guides further testing 1
  • RDW >14% with low MCV indicates iron deficiency anemia, while RDW ≤14% with low MCV suggests thalassemia 1
  • Reticulocyte count distinguishes decreased bone marrow production from increased destruction or blood loss 1

Iron Studies

  • Measure serum ferritin to assess iron stores; levels <30 μg/L indicate iron deficiency in the absence of inflammation 1
  • Check transferrin saturation to evaluate functional iron availability 1
  • Obtain CRP to identify inflammation that may falsely elevate ferritin (ferritin up to 100 μg/L may still indicate iron deficiency when inflammation is present) 1
  • Children with ARFID show significantly lower iron intake compared to healthy controls, making iron deficiency highly prevalent 2

Micronutrient Assessment

  • Screen for vitamins B1, B2, B12, C, and K because ARFID patients meet only 20-30% of recommended intake for most vitamins 2
  • Measure zinc and potassium levels, as these are significantly lower in ARFID versus controls 2
  • Vitamin K and B12 deficiencies correlate with limited vegetable and protein intake characteristic of ARFID 3

Why These Tests Matter

Macronutrient Deficiencies Drive Micronutrient Risk

  • ARFID patients consume significantly lower total energy, protein, fat, and carbohydrates compared to healthy peers 2
  • Their diet is high in processed foods, total carbohydrates, and added sugars, but low in vegetables and protein 3
  • Vegetable and protein intake are significantly reduced, directly causing deficiencies in vitamins K, B12, iron, and zinc 3

Anemia Screening Is Essential

  • Children aged 9-18 months are at highest risk for iron deficiency anemia due to rapid growth and inadequate dietary iron 1
  • Screen all ARFID patients for anemia with hemoglobin; levels <11.0 g/dL in children aged 1-5 years meet diagnostic criteria 1, 4
  • Confirm positive screening with repeat hemoglobin or hematocrit before initiating treatment 5, 4

Electrolyte Monitoring for Refeeding Risk

  • In severely malnourished ARFID patients, phosphorus and magnesium supplementation may prevent refeeding syndrome during nutritional rehabilitation 6
  • Electrolyte imbalances can occur with aggressive refeeding, though more aggressive protocols appear well-tolerated in most cases 6

Age-Specific Screening Recommendations

High-Risk Populations (Screen Universally)

  • Screen all ARFID patients between ages 9-12 months, again at 15-18 months, then annually from ages 2-5 years 5
  • Children with limited food variety or amount are at particularly high risk for multiple deficiencies 2

Risk Factors Requiring Screening

  • Excessive cow's milk intake (>24 oz daily) 5
  • Limited iron-fortified foods in diet 5
  • History of prematurity or low birth weight 5
  • Introduction of cow's milk before age 12 months 5
  • Restricted diets or limited dietary variety (hallmark of ARFID) 2, 3

Critical Pitfalls to Avoid

  • Do not delay presumptive iron treatment in children with microcytic anemia and clear ARFID risk factors while waiting for ferritin results 1
  • Do not overlook that ARFID patients often report no fruits or vegetables in their top five food categories, making multiple micronutrient deficiencies likely 3
  • Do not assume normal hemoglobin rules out other micronutrient deficiencies; ARFID creates risk for vitamins B1, B2, C, K, zinc, and potassium deficiency independent of anemia 2
  • Do not forget that serum ferritin is an acute phase reactant; inflammation can mask iron deficiency even with ferritin up to 100 μg/L 1

Follow-Up Testing

Confirming Iron Deficiency Treatment Response

  • Repeat hemoglobin at 4 weeks after starting iron supplementation (3 mg/kg/day between meals) 5, 4
  • An increase ≥1 g/dL in hemoglobin or ≥3% in hematocrit confirms iron deficiency anemia 5, 4
  • Continue iron therapy for 2-3 additional months to replenish stores even after hemoglobin normalizes 4, 7

Non-Responsive Anemia

  • If anemia persists after 4 weeks despite compliance, obtain MCV, RDW, and serum ferritin 5
  • Serum ferritin ≤15 μg/L confirms iron deficiency; >15 μg/L suggests alternative diagnosis 7
  • Consider hematology referral if workup remains inconclusive 1

Long-Term Consequences of Untreated Deficiencies

  • Untreated iron deficiency anemia causes neurodevelopmental delays, decreased motor activity, impaired social interaction, and reduced attention span that may persist beyond school age 4, 7
  • Nutritional deficiencies from ARFID increase risk for stunted growth and developmental problems 2, 8
  • ARFID prevalence can reach 3% in the general population, making systematic nutrition screening essential at every pediatric visit 8

References

Guideline

Initial Workup for Anemia in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Anemia in 2-Year-Old Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Anemia in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nutritional risks of ARFID (avoidant restrictive food intake disorders) and related behavior.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.